Page 6 - Sight Sciences Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sight Sciences (NASDAQ:SGHT – Free Report) and Imagin Medical (OTCMKTS:IMEXF – Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Profitability This table compares Sight Sciences and Imagin Medical’s net […]

Sight Sciences (NASDAQ:SGHT – Free Report) had its target price lowered by Stifel Nicolaus from $15.00 to $13.00 in a report released on Monday, The Fly reports. Separately, Bank of America lowered their target price on Sight Sciences from $13.00 to $10.00 in a research note on Tuesday, June 6th. Two investment analysts have rated […]

Sight Sciences (NASDAQ:SGHT – Get Rating) and Nyxoah (NASDAQ:NYXH – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Analyst Recommendations This is a summary of current recommendations for […]

Shares of Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating) have been given an average rating of “Moderate Buy” by the seven research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 […]

Sight Sciences (NASDAQ:SGHT – Get Rating) had its price target cut by Bank of America from $13.00 to $10.00 in a research report report published on Tuesday, The Fly reports. Sight Sciences Trading Down 1.8 % Shares of Sight Sciences stock opened at $7.81 on Tuesday. The firm has a 50-day simple moving average of […]